A citation-based method for searching scientific literature

Vlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Terrance D Barrett, Michele Weidner-Wells, Hsiaowei Deng, David R Matthews, Bruce Neal. Lancet Diabetes Endocrinol 2018
Times Cited: 288



Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen, Cees J Tack, Mette Thomsen, Tina Vilsbøll, Mark L Warren, Stephen C Bain. N Engl J Med 2019
Times Cited: 521




List of shared articles



Times cited

Redefining diabetes mellitus treatments according to different mechanisms beyond hypoglycaemic effect.
Savina Nodari, Francesco Fioretti, Francesco Barilla. Heart Fail Rev 2022
0



GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis.
Thomas Karagiannis, Apostolos Tsapas, Eleni Athanasiadou, Ioannis Avgerinos, Aris Liakos, David R Matthews, Eleni Bekiari. Diabetes Res Clin Pract 2021
10

Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis.
Takashi Kadowaki, Fumiko Yamamoto, Yusuke Taneda, Yusuke Naito, Douglas Clark, Søren S Lund, Tomoo Okamura, Kohei Kaku. Expert Opin Drug Saf 2021
1

From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes.
Ofri Mosenzon, Stefano Del Prato, Meir Schechter, Lawrence A Leiter, Antonio Ceriello, Ralph A DeFronzo, Itamar Raz. Cardiovasc Diabetol 2021
8

How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR.
Clara García-Carro, Ander Vergara, Sheila Bermejo, María A Azancot, Ana I Sánchez-Fructuoso, M Dolores Sánchez de la Nieta, Irene Agraz, María José Soler. J Clin Med 2021
3